Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study

Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study

Abstract Background The development and rapid uptake of immune checkpoint inhibitors (CPI) has changed the outlook for patients with cancer. However, CPIs have different adverse event (AE) profiles to other systemic therapies, and prompt AE management is essential to assure optimal outcomes. In orde...

Full description

Bibliographic Details
Main Authors: Liz Jamieson, Martin D. Forster, Kam Zaki, Sanjena Mithra, Heena Alli, Anne O’Connor, Apini Patel, Ian C. K. Wong, Pinkie Chambers
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Cancer
Subjects:
Immunotherapy
Immune checkpoint inhibitors
Immune-related adverse events
Lung cancer
Online Access:http://link.springer.com/article/10.1186/s12885-020-07215-3

Internet

http://link.springer.com/article/10.1186/s12885-020-07215-3

Similar Items